Evidence map›Paper›PMID 35147139›Full record

ArticleBiomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia2023

Risk factors for tumors or leukemia development in the first two years of life.

Hana Wiedermannova, Peter Mudry, Jan Pavlicek, Hana Tomaskova, Andrea Hladikova, Hana Palova, Petra Vesela, Ondrej Slaby, Jaroslav Sterba

Open access · goldAbstract read
PubMed Publisher
In one paragraph

Article in Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 99% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 7 institutions in 1 country.

Hana WiedermannovaDepartment of Neonatology, University Hospital Ostrava, Ostrava, Czech Republic.
Peter MudryFaculty of Medicine, Masaryk University, Brno, Czech Republic.
Jan PavlicekDepartment of Pediatrics and Prenatal Cardiology, University Hospital Ostrava, Ostrava, Czech Republic.
Hana TomaskovaDepartment of Epidemiology and Public Health, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.
Andrea HladikovaDepartment of Medical Genetics, University Hospital of Ostrava, Ostrava, Czech Republic.
Hana PalovaCEITEC - Central European Institute of Technology, Masaryk University, Brno, Czech Republic.
Petra VeselaCEITEC - Central European Institute of Technology, Masaryk University, Brno, Czech Republic.
Ondrej SlabyCEITEC - Central European Institute of Technology, Masaryk University, Brno, Czech Republic.
Jaroslav SterbaFaculty of Medicine, Masaryk University, Brno, Czech Republic.
Central European Institute of Technology – Masaryk University · CZMasaryk University · CZSt. Anne's University Hospital Brno · CZUniversity Hospital Brno · CZUniversity Hospital Hradec Králové · CZUniversity Hospital Ostrava · CZUniversity of Ostrava · CZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThe objective of this study was to determine the incidence of neoplastic diseases and associated risk factors in the early stages of life.

methodsData were retrospectively assessed in 730,000 live births between 2000 and 2019. The occurrence of tumors was monitored in the neonatal, infant (1-12 months), and toddler (13-24 months) periods. Risk factors were divided into demographic, internal, and environmental factors. The control group consisted of subjects in the same age category without oncological diseases.

resultsA total of 452 neoplastic diseases were diagnosed in the study sample. In total, 24% (110/452) manifested during the neonatal period, 45% (203/452) in infants, and 31% (139/452) at the age of 13-24 months. Any genetic disease (OR 26.68; 95% CI 7.64-93.12) and medications used by the mother (OR 3.07; 95% CI 1.32-7.15) were identified as risk factors. Without adjustment for all factors, asphyxia in the first minute, a younger age of the mother, lower pregnancy, and the presence of a congenital defect manifested themselves as risk factors.

conclusionsThe highest risk factors for the development of early childhood tumors were identified as with medications used by the mother before or during pregnancy and genetic diseases.

Indexed as

LeukemiaNeoplasmsChild, PreschoolFemaleHumansInfantInfant, NewbornMothersPregnancyRetrospective StudiesRisk Factorsearly-aged periodepidemiologyneoplastic diseaserisk factors

Identifiers

PMID35147139
OpenAlexW4211166220

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.